AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1978615 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 45
Study 1978615 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 45
Study 1978615 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive medications
Number of subjects: 45
Study 1978615 — intervention group
Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 45
Study 332262 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg hemisuccinate hydrocortisone (HSHC)
Number of subjects: 14
Study 332262 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg/kg hemisuccinate hydrocortisone (HSHC)
Number of subjects: 14
Study 332262 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg/kg hemisuccinate hydrocortisone (HSHC)
Number of subjects: 14
Study 332262 — intervention group
Group type: COMPARATOR
Intervention: salbutamol
Number of subjects: 14
Study 332262 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 31971419 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly Valued Drinking Contexts (HVCs)
Number of subjects: 0
Study 31971419 — intervention group
Group type: EXPERIMENTAL
Intervention: AUD severity
Number of subjects: 0
Study 31517322 — intervention group
Group type: EXPERIMENTAL
Intervention: Squamous cell carcinoma (SCC) patients with ERF
Number of subjects: 94
Study 31517322 — intervention group
Group type: COMPARATOR
Intervention: Definitive chemoradiation
Number of subjects: 94
Study 27778328 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin 10 mg every other day
Number of subjects: 45
Study 27778328 — intervention group
Group type: COMPARATOR
Intervention: Antiseborrheic topical treatment
Number of subjects: 45
Study 25273554 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 664
Study 25273554 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 664
Study 25273554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 664
Study 23705535 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth SRP + SZ (satranidazole)
Number of subjects: 66
Study 23705535 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth SRP + placebo
Number of subjects: 66
Study 21748532 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional 1 (Int.1) without fundoscopic changes
Number of subjects: 86
Study 21748532 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional 2 (Int.2) with fundoscopic changes
Number of subjects: 86
Study 21748532 — intervention group
Group type: COMPARATOR
Intervention: Control group (without history of HCQ use)
Number of subjects: 86
Study 19786440 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDCAP-based care (N = 56)
Number of subjects: 110
Study 16683674 — intervention group
Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid for 15 seconds
Number of subjects: 30
Study 16683674 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-rinse conditioner (NRC) for 20 seconds
Number of subjects: 30
Study 16683674 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (CSEB) for 20 seconds
Number of subjects: 30
Study 15477550 — intervention group
Group type: EXPERIMENTAL
Intervention: l-methionine 6 g/day in two divided doses
Number of subjects: 56
Study 15477550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 11251923 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound for diagnosis of endometrioma
Number of subjects: 132
Study 11251923 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound for diagnosis of dermoid cysts
Number of subjects: 132
Study 11251923 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound
Number of subjects: 132
Study 9230640 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/day
Number of subjects: 28
Study 8501794 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchiectomy and mitomycin C
Number of subjects: 119
Study 8501794 — intervention group
Group type: COMPARATOR
Intervention: Orchiectomy alone
Number of subjects: 119
Study 2940301 — intervention group
Group type: EXPERIMENTAL
Intervention: Therafectin (SM-1213)
Number of subjects: 12
Study 2940301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31740111 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief computerized intervention targeting perceived burdensomeness
Number of subjects: 250
Study 31740111 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief computerized intervention targeting thwarted belongingness
Number of subjects: 250
Study 31740111 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief computerized intervention targeting anxiety sensitivity
Number of subjects: 250
Study 31740111 — intervention group
Group type: COMPARATOR
Intervention: Repeated contact control condition
Number of subjects: 250
Study 29929813 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (IncoA) injection, 80–120 units, customized injection approach
Number of subjects: 33
Study 29929813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 27269740 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab followed by ipilimumab
Number of subjects: 140
Study 27269740 — intervention group
Group type: COMPARATOR
Intervention: Ipilimumab followed by nivolumab
Number of subjects: 140
Study 24675386 — intervention group
Group type: EXPERIMENTAL
Intervention: Threat condition (character had a highly contagious flu)
Number of subjects: 96
Study 24675386 — intervention group
Group type: COMPARATOR
Intervention: No-Threat condition (character accepted to graduate school)
Number of subjects: 96
Study 22937959 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-week internet-based guided self-help program followed by face-to-face psychotherapy
Number of subjects: 244
Study 22937959 — intervention group
Group type: COMPARATOR
Intervention: Control group followed by face-to-face psychotherapy
Number of subjects: 244
Study 20691435 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg/d)
Number of subjects: 70
Study 18173341 — intervention group
Group type: EXPERIMENTAL
Intervention: ALIF without reoperation (Group A)
Number of subjects: 322
Study 18173341 — intervention group
Group type: EXPERIMENTAL
Intervention: arthroplasty without repeated operation (Group C)
Number of subjects: 322
Study 18173341 — intervention group
Group type: EXPERIMENTAL
Intervention: arthroplasty (nonrandomized) without repeated operation (Group E)
Number of subjects: 322
Study 18173341 — intervention group
Group type: COMPARATOR
Intervention: ALIF with conversion to 360 degrees fusion (Group B)
Number of subjects: 322
Study 18173341 — intervention group
Group type: COMPARATOR
Intervention: arthroplasty with supplemental posterior lumbar fixation (Group D)
Number of subjects: 322
Study 18173341 — intervention group
Group type: COMPARATOR
Intervention: arthroplasty (nonrandomized) with supplemental posterior lumbar fixation (Group F)
Number of subjects: 322
Study 15817001 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented walking intervention
Number of subjects: 91
Study 12876172 — intervention group
Group type: EXPERIMENTAL
Intervention: HaloLite nebuliser
Number of subjects: 15
Study 12876172 — intervention group
Group type: COMPARATOR
Intervention: Pari LC Plus nebuliser
Number of subjects: 15
Study 10099857 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine 10 mg at bedtime for 1 and 3 months
Number of subjects: 10
Study 10099857 — intervention group
Group type: COMPARATOR
Intervention: Bromocriptine (BRC) 2.5 mg
Number of subjects: 10
Study 8904947 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 0
Study 1651201 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg.day‐1)
Number of subjects: 10
Study 6617932 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulation during the first stage of labor
Number of subjects: 630
Study 6617932 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-ambulant)
Number of subjects: 630
Study 31686768 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic UG1601
Number of subjects: 0
Study 29870446 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid + lidocaine (40 mg triamcinolone acetonide plus 5 mL of 1% lidocaine)
Number of subjects: 108
Study 29870446 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid + lidocaine
Number of subjects: 108
Study 29870446 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine alone (6 mL of 1% lidocaine)
Number of subjects: 108
Study 26135532 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 40% of maximal inspiratory pressure (MIP) for 6 weeks
Number of subjects: 38
Study 26135532 — intervention group
Group type: COMPARATOR
Intervention: Control group received IMT at 5% of MIP for 6 weeks
Number of subjects: 38
Study 25323182 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin + clavulanic acid (Group A)
Number of subjects: 80
Study 25323182 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxacillin (Group B)
Number of subjects: 80
Study 25323182 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics (Group C)
Number of subjects: 80
Study 23035641 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute manualized Swedish massage protocol
Number of subjects: 0
Study 23035641 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-minute manualized Swedish massage protocol
Number of subjects: 0
Study 19777494 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment under per-protocol analysis
Number of subjects: 0
Study 19777494 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncompliance by switching treatment
Number of subjects: 0
Study 19777494 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncompliance by subjects not receiving any treatment
Number of subjects: 0
Study 17335319 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (15-30 mg/day)
Number of subjects: 300
Study 17335319 — intervention group
Group type: COMPARATOR
Intervention: Perphenazine (8-64 mg/day)
Number of subjects: 300
Study 15215002 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive-pressure ventilation for 2 hours
Number of subjects: 20
Study 15215002 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy for 2 hours
Number of subjects: 20
Study 12224581 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg praziquantel
Number of subjects: 0
Study 12224581 — intervention group
Group type: COMPARATOR
Intervention: 40 mg/kg praziquantel
Number of subjects: 0
Study 9642894 — intervention group
Group type: EXPERIMENTAL
Intervention: Both sorts of information (outcome information and self‐efficacy‐enhancing information)
Number of subjects: 1540
Study 9642894 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐efficacy‐enhancing information only
Number of subjects: 1540
Study 9642894 — intervention group
Group type: COMPARATOR
Intervention: No information (control group)
Number of subjects: 1540
Study 9642894 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched treatment
Number of subjects: 1540
Study 9642894 — intervention group
Group type: EXPERIMENTAL
Intervention: Mismatched treatment
Number of subjects: 1540
Study 8076488 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary closure with drainage
Number of subjects: 45
Study 8076488 — intervention group
Group type: COMPARATOR
Intervention: Packing
Number of subjects: 45
Study 2518871 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg nocte
Number of subjects: 161
Study 2518871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study 780103 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CARB)
Number of subjects: 38
Study 780103 — intervention group
Group type: COMPARATOR
Intervention: Diphenylhydantoin (DPH)
Number of subjects: 38
Study 31218531 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication + CT
Number of subjects: 20
Study 31218531 — intervention group
Group type: COMPARATOR
Intervention: Medication + non-active training
Number of subjects: 20
Study 31003673 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with exercise therapy and conventional rehabilitation training
Number of subjects: 0
Study 31003673 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation training alone
Number of subjects: 0
Study 28493030 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Aerobic Interval Training (HIIT) (>90% of maximal heart rate, 85% VO2max)
Number of subjects: 19
Study 28493030 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT) (70% of maximal heart rate, 60% VO2max)
Number of subjects: 19
Study 28493030 — intervention group
Group type: COMPARATOR
Intervention: Control (REST)
Number of subjects: 19
Study 28493030 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Aerobic Interval Training (HIIT)
Number of subjects: 19
Study 28493030 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 19
Study 25304294 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-type dietary pattern (MDP)
Number of subjects: 7216
Study 25304294 — intervention group
Group type: COMPARATOR
Intervention: Western dietary pattern (WDP)
Number of subjects: 7216
Study 23989947 — intervention group
Group type: EXPERIMENTAL
Intervention: Plitidepsin 2.4 mg m(‐2) combined with DTIC 800 mg m(‐2) q4wk (n = 38)
Number of subjects: 58
Study 23989947 — intervention group
Group type: COMPARATOR
Intervention: Single-agent plitidepsin 3.2 mg m(‐2) (n = 20)
Number of subjects: 58
Study 22095049 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 1100
Study 22095049 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 1100
Study 22095049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1100
Study 22095049 — intervention group
Group type: COMPARATOR
Intervention: Etanercept, interferon-γ, bosentan, ambrisentan, imatinib, sildenafil
Number of subjects: 1100
Study 18331462 — intervention group
Group type: EXPERIMENTAL
Intervention: Asimadoline 0.5 mg
Number of subjects: 40
Study 18331462 — intervention group
Group type: EXPERIMENTAL
Intervention: Asimadoline 1.0 mg
Number of subjects: 40
Study 18331462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 16709209 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week scan group
Number of subjects: 39572
Study 16709209 — intervention group
Group type: COMPARATOR
Intervention: 18-week scan group
Number of subjects: 39572
Study 15656399 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (curantyl, 100 mg a week)
Number of subjects: 2333
Study 15656399 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2333
Study 11720042 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical calcipotriol
Number of subjects: 40
Study 11720042 — intervention group
Group type: COMPARATOR
Intervention: Topical tretinoin
Number of subjects: 40
Study 9144756 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician message
Number of subjects: 2233
Study 9144756 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician message and BSE class
Number of subjects: 2233
Study 9144756 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician message, BSE class, and reinforcement (phone and postcard)
Number of subjects: 2233
Study 8181800 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril 5 mg
Number of subjects: 6
Study 8181800 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril 20 mg
Number of subjects: 6
Study 8181800 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril (5 mg and 20 mg)
Number of subjects: 6
Study 8181800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 3371098 — intervention group
Group type: EXPERIMENTAL
Intervention: Single sclerotherapy treatment with tetracycline at a dose of 20 mg/kg
Number of subjects: 50
Study 3371098 — intervention group
Group type: COMPARATOR
Intervention: Two sclerotherapy treatments with tetracycline
Number of subjects: 50
Study 30343531 — intervention group
Group type: EXPERIMENTAL
Intervention: IXEQ2W (80 mg subcutaneous ixekizumab every 2 weeks)
Number of subjects: 316
Study 30343531 — intervention group
Group type: EXPERIMENTAL
Intervention: IXEQ4W (80 mg subcutaneous ixekizumab every 4 weeks)
Number of subjects: 316
Study 30343531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 316
Study 30343531 — intervention group
Group type: EXPERIMENTAL
Intervention: IXEQ2W and IXEQ4W
Number of subjects: 316
Study 30343531 — intervention group
Group type: EXPERIMENTAL
Intervention: IXEQ2W
Number of subjects: 316
Study 29095374 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavioral Therapy-Case Management (DBT-CM)
Number of subjects: 130
Study 29095374 — intervention group
Group type: COMPARATOR
Intervention: Health Promotion (HP)
Number of subjects: 130
Study 25460339 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term mild hypothermia (34-35 °C) for 5 days
Number of subjects: 300
Study 25460339 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (36-37 °C)
Number of subjects: 300
Study 22717286 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle education programme (6 sessions over 7 ± 1 months)
Number of subjects: 198
Study 22717286 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 198
Study 22717286 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 198
Study 22026392 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral atorvastatin 40 mg/day
Number of subjects: 42
Study 22026392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 18773915 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Internet arm (n=81; instantaneous web‐based tailored feedback)
Number of subjects: 163
Study 18773915 — intervention group
Group type: COMPARATOR
Intervention: Standard Internet arm (n=82; websites currently available to the public)
Number of subjects: 163
Study 16541933 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive rehabilitation programme (4 rehabilitation sessions over 10 days in 18 months)
Number of subjects: 76
Study 16541933 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 76
Study 12788572 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 291
Study 12788572 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine plus iron supplementation
Number of subjects: 291
Study 12788572 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation only
Number of subjects: 291
Study 12788572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study 10952952 — intervention group
Group type: COMPARATOR
Intervention: Control diet (low in fruits, vegetables, and dairy products)
Number of subjects: 118
Study 10952952 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruits and vegetables diet
Number of subjects: 118
Study 10952952 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination diet (rich in fruits, vegetables, and low-fat dairy products, reduced in saturated and total fat)
Number of subjects: 118
Study 8620234 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium, 20 mg four times a day for 8 weeks and 20 mg three times a day for 8 weeks
Number of subjects: 100
Study 8620234 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide, 500 micrograms twice a day for 8 weeks and 250 micrograms twice a day for 8 weeks
Number of subjects: 100
Study 8620234 — intervention group
Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 100
Study 1468164 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg three times a day for three days)
Number of subjects: 18
Study 1468164 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 1468164 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 18
Study 3882677 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 3882677 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0
Study 3882677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31340957 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine insemination in the natural cycle
Number of subjects: 416
Study 31340957 — intervention group
Group type: COMPARATOR
Intervention: Intracervical insemination in the natural cycle
Number of subjects: 416
Study 29240594 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilayer skin interface support system (Bedcare) used on top of a viscoelastic foam mattress (Formafoam)
Number of subjects: 206
Study 29240594 — intervention group
Group type: COMPARATOR
Intervention: Viscoelastic foam mattress (Formafoam) covered with a cotton sheet
Number of subjects: 206
Study 27390378 — intervention group
Group type: EXPERIMENTAL
Intervention: Secure E-mails
Number of subjects: 733
Study 27390378 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone calls
Number of subjects: 733
Study 27390378 — intervention group
Group type: EXPERIMENTAL
Intervention: Contacting clinic directors
Number of subjects: 733
Study 27390378 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 733
Study 24930596 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging (TXT)
Number of subjects: 44
Study 24930596 — intervention group
Group type: COMPARATOR
Intervention: Paper-and-pencil (PNP)
Number of subjects: 44
Study 23294774 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive, dose-finding, seamless phase 2/3 trial
Number of subjects: 0
Study 23294774 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug supply management for nine treatment arms
Number of subjects: 0
Study 19830496 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative quality of life (QoL) measurements
Number of subjects: 199
Study 19830496 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative quality of life (QoL) measurements
Number of subjects: 199
Study 17010115 — intervention group
Group type: EXPERIMENTAL
Intervention: Active, multifaceted educational intervention using the WHO Reproductive Health Library (RHL) over a period of 6 months.
Number of subjects: 1000
Study 17010115 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1000